FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

CUSIP: 31189P102

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
122,342,805
Total 13F shares
35,346,074
Share change
+9,934,585
Total reported value
$215,961,575
Price per share
$6.11
Number of holders
78
Value change
+$67,123,779
Number of buys
46
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FRANKLIN RESOURCES INC
13F
Company
5%
6,076,879
$24,064,000 30 Sep 2017
13F
FMR LLC
13F
Company
3.2%
3,970,785
$15,724,000 30 Sep 2017
13F
Polaris Venture Management Co. V, L.L.C.
13F
Company
2%
2,473,186
$9,794,000 30 Sep 2017
13F
EcoR1 Capital, LLC
13F
Company
1.8%
2,262,678
$8,960,000 30 Sep 2017
13F
BlackRock Finance, Inc.
13F
Company
1.4%
1,661,794
$6,580,000 30 Sep 2017
13F
Redmile Group, LLC
13F
Company
1.2%
1,419,058
$5,619,000 30 Sep 2017
13F
VANGUARD GROUP INC
13F
Company
1%
1,282,993
$5,080,000 30 Sep 2017
13F
683 Capital Management, LLC
13F
Company
0.55%
678,800
$2,688,000 30 Sep 2017
13F
MORGAN STANLEY
13F
Company
0.48%
581,237
$2,302,000 30 Sep 2017
13F
Casdin Capital, LLC
13F
Company
0.45%
550,000
$2,178,000 30 Sep 2017
13F
STATE STREET CORP
13F
Company
0.37%
453,661
$1,796,000 30 Sep 2017
13F
NORTHERN TRUST CORP
13F
Company
0.32%
392,950
$1,556,000 30 Sep 2017
13F
KINGDON CAPITAL MANAGEMENT, L.L.C.
13F
Company
0.32%
387,294
$1,534,000 30 Sep 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.25%
302,431
$1,197,000 30 Sep 2017
13F
Endurant Capital Management LP
13F
Company
0.22%
272,700
$1,080,000 30 Sep 2017
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.21%
256,000
$1,014,000 30 Sep 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.2%
243,754
$965,000 30 Sep 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.18%
219,900
$871,000 30 Sep 2017
13F
Telemetry Investments, L.L.C.
13F
Company
0.13%
160,000
$634,000 30 Sep 2017
13F
Bank of New York Mellon Corp
13F
Company
0.13%
152,937
$606,000 30 Sep 2017
13F
Neuberger Berman Group LLC
13F
Company
0.11%
133,000
$527,000 30 Sep 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.1%
126,226
$500,000 30 Sep 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.08%
102,021
$404,000 30 Sep 2017
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.08%
92,790
$367,000 30 Sep 2017
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.06%
78,126
$318,000 30 Sep 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.06%
70,992
$281,000 30 Sep 2017
13F
ALGERT GLOBAL LLC
13F
Company
0.06%
70,677
$280,000 30 Sep 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.05%
66,000
$262,000 30 Sep 2017
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.05%
65,000
$257,000 30 Sep 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.05%
62,700
$248,000 30 Sep 2017
13F
Russell Investments Group, Ltd.
13F
Company
0.05%
59,168
$234,000 30 Sep 2017
13F
Numeric Investors LLC
13F
Company
0.04%
44,100
$175,000 30 Sep 2017
13F
RHUMBLINE ADVISERS
13F
Company
0.03%
41,527
$164,000 30 Sep 2017
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.03%
40,500
$160,000 30 Sep 2017
13F
Hochman Cole Investment Advisors, Inc.
13F
Company
0.03%
39,838
$158,000 30 Sep 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.03%
35,044
$138,000 30 Sep 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.03%
34,800
$138,000 30 Sep 2017
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.02%
30,000
$119,000 30 Sep 2017
13F
CREDIT SUISSE AG/
13F
Company
0.02%
28,467
$112,000 30 Sep 2017
13F
Creative Planning
13F
Company
0.02%
28,000
$111,000 30 Sep 2017
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
26,413
$108,000 30 Sep 2017
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.02%
25,561
$101,000 30 Sep 2017
13F
Crestline Management, LP
13F
Company
0.02%
24,174
$96,000 30 Sep 2017
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.02%
23,500
$93,000 30 Sep 2017
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.02%
23,495
$93,000 30 Sep 2017
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.02%
21,533
$85,000 30 Sep 2017
13F
Nationwide Fund Advisors
13F
Company
0.02%
21,117
$84,000 30 Sep 2017
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.02%
20,651
$82,000 30 Sep 2017
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.02%
20,000
$79,000 30 Sep 2017
13F
Virtu Financial LLC
13F
Company
0.02%
18,493
$73,000 30 Sep 2017
13F

Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q4 2017

As of 31 Dec 2017, FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,346,074 shares. The largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, Redmile Group, LLC, Casdin Capital, LLC, Polaris Venture Management Co. V, L.L.C., BlackRock Inc., Vanguard Group Inc, 683 Capital Management, LLC, Endurant Capital Management LP, and STATE STREET CORP. This page lists 78 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders
71
Q4 2017 holders
78
Holder diff
7
Investor Q3 2017 Shares Q4 2017 Shares Share Diff Share Chg % Q3 2017 Value $ Q4 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.